{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:45:22Z","timestamp":1791999922376,"version":"4.4.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073923"],"award-info":[{"award-number":["82073923"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003849"],"award-info":[{"award-number":["82003849"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.dmd.2026.100353","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T15:28:52Z","timestamp":1782746932000},"page":"100353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["PI3K-AKT-P-gp\/Mrp2 signaling pathway drives the accelerated hepatic clearance of encapsulated docetaxel of PEGylated liposomes"],"prefix":"10.1016","volume":"54","author":[{"given":"Jianquan","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiya","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunna","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7787-2638","authenticated-orcid":false,"given":"Weidong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dmd.2026.100353_bib1","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ejmech.2019.01.007","article-title":"Composition design and medical application of liposomes","volume":"164","author":"Li","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.dmd.2026.100353_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120571","article-title":"Design of liposomes as drug delivery system for therapeutic applications","volume":"601","author":"Guimar\u00e3es","year":"2021","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.dmd.2026.100353_bib3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2174\/1567201819666220324093821","article-title":"Liposome nanoparticles as a novel drug delivery system for therapeutic and diagnostic applications","volume":"20","author":"Li","year":"2023","journal-title":"Curr Drug Deliv"},{"key":"10.1016\/j.dmd.2026.100353_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemphyslip.2020.105036","article-title":"Role of stealth lipids in nanomedicine-based drug carriers","volume":"235","author":"Rastogi","year":"2021","journal-title":"Chem Phys Lipids"},{"issue":"Pt A","key":"10.1016\/j.dmd.2026.100353_bib5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"10.1016\/j.dmd.2026.100353_bib6","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0022-3565(24)35391-1","article-title":"Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes","volume":"292","author":"Dams","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"issue":"12","key":"10.1016\/j.dmd.2026.100353_bib7","doi-asserted-by":"crossref","first-page":"8733","DOI":"10.1021\/acsnano.3c11165","article-title":"Free PEG suppresses anaphylaxis to PEGylated nanomedicine in swine","volume":"18","author":"Shen","year":"2024","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.dmd.2026.100353_bib8","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12951-025-03209-0","article-title":"Emerging strategies against accelerated blood clearance phenomenon of nanocarrier drug delivery systems","volume":"23","author":"Pan","year":"2025","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.dmd.2026.100353_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112502","article-title":"Impact of anti-PEG antibody affinity on accelerated blood clearance of pegylated epoetin beta in mice","volume":"146","author":"Chang","year":"2022","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"10.1016\/j.dmd.2026.100353_bib10","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.imbio.2015.06.005","article-title":"Anti-PEG IgM and complement system are required for the association of second doses of PEGylated liposomes with splenic marginal zone B cells","volume":"220","author":"Shimizu","year":"2015","journal-title":"Immunobiology"},{"key":"10.1016\/j.dmd.2026.100353_bib11","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jconrel.2021.12.025","article-title":"A preliminary study of the innate immune memory of Kupffer cells induced by PEGylated nanoemulsions","volume":"343","author":"Liu","year":"2022","journal-title":"J Control Release"},{"issue":"4","key":"10.1016\/j.dmd.2026.100353_bib12","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1124\/dmd.118.085340","article-title":"Induction of cytochrome P450 involved in the accelerated blood clearance phenomenon induced by PEGylated liposomes in vivo","volume":"47","author":"Wang","year":"2019","journal-title":"Drug Metab Dispos"},{"issue":"8","key":"10.1016\/j.dmd.2026.100353_bib13","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1124\/dmd.119.086769","article-title":"Activation of pregnane X receptor-cytochrome P450s axis: a possible reason for the enhanced accelerated blood clearance phenomenon of PEGylated liposomes in vivo","volume":"47","author":"Wang","year":"2019","journal-title":"Drug Metab Dispos"},{"issue":"12","key":"10.1016\/j.dmd.2026.100353_bib14","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1124\/dmd.123.001496","article-title":"Activation of CYP3A by accelerated blood clearance phenomenon potentiates the hepatocellular carcinoma-targeting therapeutic effects of PEGylated anticancer prodrug liposomes","volume":"51","author":"Zhang","year":"2023","journal-title":"Drug Metab Dispos"},{"issue":"11","key":"10.1016\/j.dmd.2026.100353_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmd.2025.100172","article-title":"Activation of PXR-Oatp1a\/b\/P-gp\/Mrp2 axis mediates the accelerated blood and liver clearance of PEGylated liposomes","volume":"53","author":"Pan","year":"2025","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"10.1016\/j.dmd.2026.100353_bib16","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12943-022-01587-9","article-title":"Hsa-miR-3178\/RhoB\/PI3K\/Akt, a novel signaling pathway regulates ABC transporters to reverse gemcitabine resistance in pancreatic cancer","volume":"21","author":"Gu","year":"2022","journal-title":"Mol Cancer"},{"issue":"3","key":"10.1016\/j.dmd.2026.100353_bib17","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.3390\/molecules28031087","article-title":"Development of polymersomes co-delivering doxorubicin and melittin to overcome multidrug resistance","volume":"28","author":"Han","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.dmd.2026.100353_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.783317","article-title":"Cajanol sensitizes A2780\/taxol cells to paclitaxel by inhibiting the PI3K\/Akt\/NF-\u03baB signaling pathway","volume":"12","author":"Sui","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.dmd.2026.100353_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.803114","article-title":"Phenethylisothiocyanate potentiates platinum therapy by reversing cisplatin resistance in cervical cancer","volume":"13","author":"Mahapatra","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.dmd.2026.100353_bib20","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jconrel.2023.03.017","article-title":"cRGD-targeted heparin nanoparticles for effective dual drug treatment of cisplatin-resistant ovarian cancer","volume":"356","author":"Liang","year":"2023","journal-title":"J Control Release"},{"issue":"11","key":"10.1016\/j.dmd.2026.100353_bib21","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202101626RR","article-title":"Dexmedetomidine attenuates renal ischemia\u2013reperfusion injury through activating PI3K\/Akt-eNOS signaling via \u03b12 adrenoreceptors in renal microvascular endothelial cells","volume":"36","author":"Shan","year":"2022","journal-title":"FASEB J"},{"issue":"1","key":"10.1016\/j.dmd.2026.100353_bib22","article-title":"Tanshinone IIA affects the malignant growth of Cholangiocarcinoma cells by inhibiting the PI3K-Akt-mTOR pathway","volume":"11","author":"Liu","year":"2021","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.dmd.2026.100353_bib23","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1007\/s10571-023-01371-3","article-title":"Inhibiting PI3K\/Akt-signaling pathway improves neurobehavior changes in anti-NMDAR encephalitis mice by ameliorating blood\u2013brain barrier disruption and neuronal damage","volume":"43","author":"Gong","year":"2023","journal-title":"Cell Mol Neurobiol"},{"issue":"10","key":"10.1016\/j.dmd.2026.100353_bib24","doi-asserted-by":"crossref","DOI":"10.1590\/acb371004","article-title":"Cardioprotective action of aprepitant in a rat model of ischemia-reperfusioninduced myocardial injury: role of PI3K-AkT-GSK-3\u03b2-HIF-1\u03b1 signaling pathway","volume":"37","author":"Qian","year":"2022","journal-title":"Acta Cir Bras"},{"issue":"1","key":"10.1016\/j.dmd.2026.100353_bib25","first-page":"35","article-title":"Genistein attenuates monocrotaline-induced pulmonary arterial hypertension in rats by activating PI3K\/Akt\/eNOS signaling","volume":"32","author":"Zheng","year":"2017","journal-title":"Histol Histopathol"},{"issue":"4","key":"10.1016\/j.dmd.2026.100353_bib26","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1080\/08923973.2022.2055565","article-title":"LY294002 attenuates inflammatory response in endotoxin-induced uveitis by downregulating JAK3 and inactivating the PI3K\/Akt signaling","volume":"44","author":"Wu","year":"2022","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"3","key":"10.1016\/j.dmd.2026.100353_bib27","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3109\/03602530903491881","article-title":"Sandwich-cultured hepatocytes: an in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity","volume":"42","author":"Swift","year":"2010","journal-title":"Drug Metab Rev"},{"issue":"2","key":"10.1016\/j.dmd.2026.100353_bib28","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ejpb.2008.08.010","article-title":"A Caco-2 cell based screening method for compounds interacting with MRP2 efflux protein","volume":"71","author":"Siissalo","year":"2009","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"10.1016\/j.dmd.2026.100353_bib29","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1124\/jpet.102.044107","article-title":"Pharmacokinetics of 5 (and 6)-carboxy-2\u2032,7\u2032-dichlorofluorescein and its diacetate promoiety in the liver","volume":"304","author":"Zamek-Gliszczynski","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.dmd.2026.100353_bib30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0168-3659(02)00462-5","article-title":"Accelerated clearance of PEGylated liposomes in rats after repeated injections","volume":"88","author":"Ishida","year":"2003","journal-title":"J Control Release"},{"issue":"1","key":"10.1016\/j.dmd.2026.100353_bib31","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.xphs.2018.10.027","article-title":"Time interval of two injections and first-dose dependent of accelerated blood clearance phenomenon induced by PEGylated liposomal gambogenic acid: the contribution of PEG-specific IgM","volume":"108","author":"Wang","year":"2019","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1016\/j.dmd.2026.100353_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12989-024-00562-0","article-title":"ROS\/mtROS promotes TNTs formation via the PI3K\/AKT\/mTOR pathway to protect against mitochondrial damages in glial cells induced by engineered nanomaterials","volume":"21","author":"Lin","year":"2024","journal-title":"Part Fibre Toxicol"},{"issue":"1","key":"10.1016\/j.dmd.2026.100353_bib33","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s12935-023-03173-5","article-title":"LncRNA AGAP2 antisense RNA 1 stabilized by insulin-like growth factor 2 mRNA binding protein 3 promotes macrophage M2 polarization in clear cell renal cell carcinoma through regulation of the microRNA-9-5p\/THBS2\/PI3K-Akt pathway","volume":"23","author":"Xu","year":"2023","journal-title":"Cancer Cell Int"},{"issue":"Pt A","key":"10.1016\/j.dmd.2026.100353_bib34","article-title":"Hepatoprotective efficacy and interventional mechanism of JianPi LiShi YangGan formula in acute-on-chronic liver failure","volume":"318","author":"Li","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.dmd.2026.100353_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.117628","article-title":"Piperine promotes PI3K\/AKT\/mTOR-mediated gut-brain autophagy to degrade \u03b1-Synuclein in Parkinson\u2019s disease rats","volume":"322","author":"Yu","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.dmd.2026.100353_bib36","article-title":"Overexpression of ABCC1 confers drug resistance to betulin","volume":"11","author":"Chen","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.dmd.2026.100353_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103207","article-title":"Redistribution of defective mitochondria-mediated dihydroorotate dehydrogenase imparts 5-fluorouracil resistance in colorectal cancer","volume":"73","author":"Dong","year":"2024","journal-title":"Redox Biol"},{"issue":"10","key":"10.1016\/j.dmd.2026.100353_bib38","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1002\/jps.10199","article-title":"Effect of interferons on P-glycoprotein-mediated rhodamine-123 efflux in cultured rat hepatocytes","volume":"91","author":"Akazawa","year":"2002","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.dmd.2026.100353_bib39","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1124\/dmd.114.059105","article-title":"Investigation of the impact of substrate selection on in vitro organic anion transporting polypeptide 1B1 inhibition profiles for the prediction of drug-drug interactions","volume":"43","author":"Izumi","year":"2015","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"10.1016\/j.dmd.2026.100353_bib40","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/j.xphs.2016.01.020","article-title":"Effects of polyoxyethylene alkyl ethers on the intestinal transport and absorption of rhodamine 123: a P-glycoprotein substrate by in vitro and in vivo studies","volume":"105","author":"Zhao","year":"2016","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1016\/j.dmd.2026.100353_bib41","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1080\/13880209.2021.1871634","article-title":"Influence of verapamil on the pharmacokinetics of rotundic acid in rats and its potential mechanism","volume":"59","author":"Shang","year":"2021","journal-title":"Pharm Biol"},{"issue":"1","key":"10.1016\/j.dmd.2026.100353_bib42","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41401-019-0283-z","article-title":"Leflunomide increased the renal exposure of acyclovir by inhibiting OAT1\/3 and MRP2","volume":"41","author":"Liao","year":"2019","journal-title":"Acta Pharmacol Sin"},{"issue":"7","key":"10.1016\/j.dmd.2026.100353_bib43","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1172\/JCI45023","article-title":"Inhibition of MRP4 prevents and reverses pulmonary hypertension in mice","volume":"121","author":"Hara","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.dmd.2026.100353_bib44","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ejps.2017.12.010","article-title":"Comparison among different \"revealers\" in the study of accelerated blood clearance phenomenon","volume":"114","author":"Liang","year":"2018","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10.1016\/j.dmd.2026.100353_bib45","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1038\/s41467-024-48838-5","article-title":"Rediscovery of mononuclear phagocyte system blockade for nanoparticle drug delivery","volume":"15","author":"Zelepukin","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.dmd.2026.100353_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119839","article-title":"Experimental respiratory exposure to putative Gulf War toxins promotes persistent alveolar macrophage recruitment and pulmonary inflammation","volume":"282","author":"Powers","year":"2021","journal-title":"Life Sci"},{"key":"10.1016\/j.dmd.2026.100353_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115044","article-title":"The interplay between PEGylated nanoparticles and blood immune system","volume":"200","author":"Guo","year":"2023","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"10.1016\/j.dmd.2026.100353_bib48","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pharep.2017.10.005","article-title":"P-gp is involved in the intestinal absorption and biliary excretion of afatinib in vitro and in rats","volume":"70","author":"Zhang","year":"2018","journal-title":"Pharmacol Rep"},{"issue":"10","key":"10.1016\/j.dmd.2026.100353_bib49","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.3390\/pharmaceutics13101544","article-title":"Inflammation induces changes in the functional expression of P-gp, BCRP, and MRP2: an overview of different models and consequences for drug disposition","volume":"13","author":"Saib","year":"2021","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.dmd.2026.100353_bib50","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","article-title":"Targeting PI3K\/Akt signal transduction for cancer therapy","volume":"6","author":"He","year":"2021","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"10.1016\/j.dmd.2026.100353_bib51","first-page":"1083","article-title":"A 3D in vitro model of differentiated HepG2 cell spheroids with improved liver-like properties for repeated dose high-throughput toxicity studies","volume":"88","author":"Ramaiahgari","year":"2014","journal-title":"Arch Toxicol"},{"issue":"2","key":"10.1016\/j.dmd.2026.100353_bib52","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.xphs.2015.11.008","article-title":"Sandwich-cultured hepatocytes as a tool to study drug disposition and drug-induced liver injury","volume":"105","author":"Yang","year":"2016","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.dmd.2026.100353_bib53","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jconrel.2023.07.031","article-title":"Poly(vinyl pyrrolidone) derivatives as PEG alternatives for stealth, non-toxic and less immunogenic siRNA-containing lipoplex delivery","volume":"361","author":"Berger","year":"2023","journal-title":"J Control Release"},{"issue":"3","key":"10.1016\/j.dmd.2026.100353_bib54","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0090-9556(24)15360-3","article-title":"The role of mdr1a P-glycoprotein in the biliary and intestinal secretion of doxorubicin and vinblastine in mice","volume":"28","author":"van Asperen","year":"2000","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"10.1016\/j.dmd.2026.100353_bib55","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1124\/jpet.106.101774","article-title":"Carcinogen and anticancer drug transport by Mrp2 in vivo: studies using Mrp2 (Abcc2) knockout mice","volume":"318","author":"Vlaming","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"issue":"8","key":"10.1016\/j.dmd.2026.100353_bib56","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.ejca.2004.01.024","article-title":"Improved penetration of docetaxel into the brain by co-administration of inhibitors of P-glycoprotein","volume":"40","author":"Kemper","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.dmd.2026.100353_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/srep11747","article-title":"Inhibition of P-glycoprotein gene expression and function enhances triptolide-induced hepatotoxicity in mice","volume":"5","author":"Kong","year":"2015","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.dmd.2026.100353_bib58","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.xphs.2016.11.020","article-title":"High-dose metformin may increase the concentration of atorvastatin in the liver by inhibition of multidrug resistance\u2013associated protein 2","volume":"106","author":"Shin","year":"2017","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.dmd.2026.100353_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105608","article-title":"Liver organoid as a 3D in vitro model for drug validation and toxicity assessment","volume":"169","author":"Brooks","year":"2021","journal-title":"Pharmacol Res"},{"issue":"517","key":"10.1016\/j.dmd.2026.100353_bib60","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax5516","article-title":"Reproducing human and cross-species drug toxicities using a Liver-Chip","volume":"11","author":"Jang","year":"2019","journal-title":"Sci Transl Med"},{"issue":"10","key":"10.1016\/j.dmd.2026.100353_bib61","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1093\/annonc\/mdh404","article-title":"Weekly paclitaxel combined with pegylated liposomal doxorubicin (CaelyxTM) given every 4 weeks: dose-finding and pharmacokinetic study in patients with advanced solid tumors","volume":"15","author":"Briasoulis","year":"2004","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.dmd.2026.100353_bib62","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s00280-003-0750-5","article-title":"Interaction pharmacokinetics of pegylated liposomal doxorubicin (Caelyx) on coadministration with paclitaxel or docetaxel","volume":"53","author":"Briasoulis","year":"2004","journal-title":"Cancer Chemother Pharmacol"},{"issue":"4C","key":"10.1016\/j.dmd.2026.100353_bib63","first-page":"2519","article-title":"Paclitaxel and pegylated liposomal doxorubicin in recurrent head and neck cancer: clinical and unexpected pharmacokinetic interactions","volume":"28","author":"Airoldi","year":"2008","journal-title":"Anticancer Res"},{"issue":"10","key":"10.1016\/j.dmd.2026.100353_bib64","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1124\/dmd.122.001068","article-title":"Fluorescence-based high-throughput assays for investigating cytochrome P450 enzyme-mediated drug\u2013drug interactions","volume":"51","author":"He","year":"2023","journal-title":"Drug Metab Dispos"},{"issue":"5","key":"10.1016\/j.dmd.2026.100353_bib65","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.ajpath.2014.01.025","article-title":"Transgenic expression of the human MRP2 transporter reduces cisplatin accumulation and nephrotoxicity in Mrp2-null mice","volume":"184","author":"Wen","year":"2014","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/j.dmd.2026.100353_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygeno.2025.111033","article-title":"Transcriptome analysis reveals that the injection of mesenchymal stem cells remodels extracellular matrix and complement components of the brain through PI3K\/AKT\/FOXO1 signaling pathway in a neuroinflammation mouse model","volume":"117","author":"Xu","year":"2025","journal-title":"Genomics"},{"issue":"6","key":"10.1016\/j.dmd.2026.100353_bib67","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.celrep.2014.02.014","article-title":"Autocrine effects of tumor-derived complement","volume":"6","author":"Cho","year":"2014","journal-title":"Cell Rep"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955626006227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955626006227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:54:21Z","timestamp":1791996861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955626006227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":67,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0090955626006227"],"URL":"https:\/\/doi.org\/10.1016\/j.dmd.2026.100353","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PI3K-AKT-P-gp\/Mrp2 signaling pathway drives the accelerated hepatic clearance of encapsulated docetaxel of PEGylated liposomes","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmd.2026.100353","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100353"}}